Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast

Michele Columbo

Published: 17 April 2017

Abstract

Background

Little is known about asthma in the elderly as most studies of this condition have not included this patient group. It is unclear whether leukotriene antagonists benefit older asthmatics. We studied the effect of adding montelukast to the asthma treatment of elderly subjects.

Methods

Twenty-five subjects 65 years old and older with asthma were evaluated at week 0, 1, 5, 9, 13, and 17. Each subject received montelukast 10 mg and placebo each for 8 weeks in a cross-over design.

Results

Montelukast for 4 or 8 weeks did not significantly affect ACT, daily symptom scores, number of puffs of albuterol, spirometric values, peripheral blood eosinophils, or serum IgE vs. baseline or placebo. Similar results were obtained when analyzing subgroups of patients with lower ACT, lower FEV1, and higher eosinophils.

Conclusions

In this study of elderly asthmatics, montelukast had no effect on asthma symptoms, number of puffs of albuterol, spirometric values, peripheral blood eosinophils or serum IgE. These results will require confirmation in larger patient cohorts and in patients with uncontrolled asthmatic symptoms.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: Vitamin D, the Sunshine Supplement, Has Shadowy Money Behind It https://t.co/wOlRsBJDir, see more https://t.co/CpGiFuOOYd
3hreplyretweetfavorite
Interasma Interasma - Secondhand Smoke Exposure in Childhood and Adulthood in Relation to Adult Mortality Among Never Smokers https://t.co/OiRAEbm3ti
5hreplyretweetfavorite
Interasma Interasma - Age and African-American race impact the validity and reliability of the asthma control test in persist… https://t.co/uwJyO07bis
5hreplyretweetfavorite
Interasma RT @Aller_MD: Autoinjectors are in especially high demand as the new school year begins. Reports of a shortage of EpiPens have been surfaci…
16hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Child passive smoking 'increases chronic lung risk' - BBC News https://t.co/nga9azowZF, see more https://t.co/jgCe
16hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma